Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 04:00 ET | Source: XL-protein GmbH

XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters

Freising, Germany, May 28, 2026 (GLOBE NEWSWIRE) -- XL‑protein GmbH today announced the launch of PASylANTA Therapeutics GmbH, a new Germany-based biotechnology company focused on the development of...
June 10, 2025 05:00 ET | Source: XL-protein GmbH

XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology

Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and...